HK1141719A1 - 用於製備異法戈明以及它的衍生物的新方法 - Google Patents

用於製備異法戈明以及它的衍生物的新方法

Info

Publication number
HK1141719A1
HK1141719A1 HK10108227.6A HK10108227A HK1141719A1 HK 1141719 A1 HK1141719 A1 HK 1141719A1 HK 10108227 A HK10108227 A HK 10108227A HK 1141719 A1 HK1141719 A1 HK 1141719A1
Authority
HK
Hong Kong
Prior art keywords
derivatives
new method
isofagomine
preparing
preparing isofagomine
Prior art date
Application number
HK10108227.6A
Other languages
English (en)
Inventor
Benjamin Mugrace
Alexander Tretyakov
Dan Fuerst
Kamlesh A Sheth
Philip J Rybczynski
Xiaoxiang Zhu
Original Assignee
阿米庫斯治療學公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 阿米庫斯治療學公司 filed Critical 阿米庫斯治療學公司
Publication of HK1141719A1 publication Critical patent/HK1141719A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
HK10108227.6A 2007-05-22 2010-08-30 用於製備異法戈明以及它的衍生物的新方法 HK1141719A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93951907P 2007-05-22 2007-05-22
PCT/US2008/064559 WO2008144773A1 (en) 2007-05-22 2008-05-22 New method for preparing isofagomine and its derivatives

Publications (1)

Publication Number Publication Date
HK1141719A1 true HK1141719A1 (zh) 2010-11-19

Family

ID=40122224

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15109393.7A HK1208860A1 (zh) 2007-05-22 2010-08-30 用於製備異法戈明的化合物
HK10108227.6A HK1141719A1 (zh) 2007-05-22 2010-08-30 用於製備異法戈明以及它的衍生物的新方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK15109393.7A HK1208860A1 (zh) 2007-05-22 2010-08-30 用於製備異法戈明的化合物

Country Status (14)

Country Link
US (3) US8487110B2 (zh)
EP (1) EP2152265B1 (zh)
JP (1) JP5441894B2 (zh)
KR (4) KR101650726B1 (zh)
CN (2) CN101743002B (zh)
AU (1) AU2008254594B2 (zh)
BR (1) BRPI0812381A2 (zh)
CA (1) CA2688850C (zh)
ES (1) ES2490143T3 (zh)
HK (2) HK1208860A1 (zh)
IL (2) IL202260A (zh)
MX (1) MX2009012593A (zh)
SG (1) SG183747A1 (zh)
WO (1) WO2008144773A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2485369T3 (es) 2005-06-08 2014-08-13 Amicus Therapeutics, Inc. Tratamiento de trastornos del SNC asociados con mutaciones en genes que codifican enzimas lisosómicas
DK2040548T3 (da) 2006-06-23 2012-08-13 Amicus Therapeutics Inc Fremgangsmåde til behandling af neurologiske forstyrrelser ved forøgelse af aktiviteten af beta-glucocerebrosidase
PL2638152T3 (pl) * 2010-11-08 2017-02-28 Amicus Therapeutics, Inc. Warianty rekombinowanych białek beta-glukocerebrozydaz ze zwiększoną stabilnością i zwiększoną zachowaną aktywnością katalityczną
JP6061922B2 (ja) * 2011-06-22 2017-01-18 ザ ジェネラル ホスピタル コーポレイション プロテイノパチーの処置方法
WO2016144773A1 (en) 2015-03-06 2016-09-15 Abbvie Inc. Arabinosylated glycoproteins
US11643265B1 (en) * 2017-02-06 2023-05-09 Rational Packaging Llc Corrugated offset corner elements
CN112625010B (zh) * 2020-12-31 2023-03-03 中山大学 一种9-羟基菲醌衍生物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863903A (en) 1994-03-09 1999-01-26 Novo Nordisk A/S Use of hydroxy alkyl piperidine and pyrrolidine compounds to treat diabetes
US5844102A (en) 1994-07-07 1998-12-01 University Of Maryland Baltimore County Glycohydrolase inhibitors, their preparation and use thereof
FR2751863B1 (fr) 1996-08-01 1999-01-22 Vitalitec International Support de clips hemostatiques
HUP0003362A3 (en) 1997-05-06 2001-04-28 Novo Nordisk As Piperidine derivatives and pharmaceutical compositions containing them
US6274597B1 (en) 1998-06-01 2001-08-14 Mount Sinai School Of Medicine Of New York University Method of enhancing lysosomal α-Galactosidase A
JP2001172250A (ja) * 1999-12-14 2001-06-26 Ono Pharmaceut Co Ltd グルコピラノース誘導体
US6455573B1 (en) 2000-01-07 2002-09-24 Simon Fraser University Glycosidase inhibitors and methods of synthesizing same
US8389565B2 (en) * 2000-01-07 2013-03-05 Simon Fraser University Glycosidase inhibitors and methods of synthesizing same
US6960654B2 (en) * 2002-06-11 2005-11-01 The Board Of Trustees Of The University Of Illinois Method of forming glycosidic bonds from thioglycosides using an N,N-dialkylsulfinamide
CH697574B1 (de) 2003-01-07 2008-12-15 Lanxess Deutschland Gmbh Pyrazolylarylalkine.
WO2005046611A2 (en) * 2003-11-12 2005-05-26 Amicus Therapeutics Inc. Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease
US20070065922A1 (en) * 2005-09-21 2007-03-22 Metkinen Oy Biocatalytic synthesis of aminodeoxy purine N9-beta-D-nucleosides containing 3-amino-3-deoxy-beta-D-ribofuranose, 3-amino-2,3-dideoxy-beta-D-ribofuranose, and 2-amino-2-deoxy-beta-D-ribofuranose as sugar moieties
DK1860101T3 (da) * 2006-05-24 2011-07-25 Amicus Therapeutics Inc Tartrat salt af isofagomin og fremgangsmåder til anvendelse deraf

Also Published As

Publication number Publication date
IL202260A (en) 2015-09-24
AU2008254594B2 (en) 2013-06-27
KR20100017879A (ko) 2010-02-16
KR101597499B1 (ko) 2016-02-24
JP5441894B2 (ja) 2014-03-12
IL240648A0 (en) 2015-09-24
CN104530068B (zh) 2017-05-03
HK1208860A1 (zh) 2016-03-18
KR101650726B1 (ko) 2016-08-24
US9481700B2 (en) 2016-11-01
CA2688850C (en) 2015-08-11
IL240648A (en) 2017-09-28
CN101743002B (zh) 2015-11-25
KR20160041059A (ko) 2016-04-15
US20100160638A1 (en) 2010-06-24
AU2008254594A1 (en) 2008-11-27
KR20150048924A (ko) 2015-05-07
ES2490143T3 (es) 2014-09-03
CN101743002A (zh) 2010-06-16
CN104530068A (zh) 2015-04-22
EP2152265A1 (en) 2010-02-17
SG183747A1 (en) 2012-09-27
US8487110B2 (en) 2013-07-16
CA2688850A1 (en) 2008-11-27
KR101789000B1 (ko) 2017-10-20
KR20160102320A (ko) 2016-08-29
JP2010528048A (ja) 2010-08-19
IL202260A0 (en) 2010-06-16
MX2009012593A (es) 2010-01-26
EP2152265B1 (en) 2014-06-04
EP2152265A4 (en) 2012-02-01
US20140005372A1 (en) 2014-01-02
US20170044102A1 (en) 2017-02-16
WO2008144773A1 (en) 2008-11-27
BRPI0812381A2 (pt) 2016-08-09

Similar Documents

Publication Publication Date Title
HK1121757A1 (en) Pyrroloazacyclic derivatives, preparing method and use thereof
EP2230938A4 (en) BALLASTE AND METHOD FOR THE PRODUCTION OF BUTTERFLY
EP2308884A4 (en) PROCESS FOR THE PREPARATION OF HETEROSUBSTITUTED ALKYLHALOHYDROSILANE AND ITS USE
EP2298777A4 (en) PROCESS FOR THE PREPARATION OF CLOPIDOGREL AND ITS DERIVATIVES
EP2162985A4 (en) METHOD AND APPARATUS FOR COMMUNICATING WITH NYQUIST ROTARY AUTOTRANSFORMATION PULSES
GB0813839D0 (en) An aerofoil and method for making an aerofoil
IL240648A0 (en) A new method for the preparation of isofogamine and its derivatives
HK1148697A1 (en) Method and means for obtaining bronchorelaxation
EP2235854A4 (en) ADAPTER, DEVICE AND METHOD
EP2142702A4 (en) PAPER AND MANUFACTURING METHOD THEREFOR
PT2239144E (pt) Método e dispositivo para marcação rotacional
EP2266733A4 (en) DRILLING DEVICE AND DRILLING METHOD
GB0819601D0 (en) Drilling apparatus and method
HK1212698A1 (zh) 噻唑基和噁唑基異喹哪啶以及它們的使用方法
EP2193683A4 (en) METHOD AND DEVICE FOR CONFIGURING
EP2150099A4 (en) ARRANGEMENT AND METHOD FOR PERMITTING FOREST EXPLOITATION IN MASS
EP2234626A4 (en) METHOD AND MEANS FOR PRODUCING BRONCHORELAXATION
HRP20150775T1 (en) Method for preparing hypoallergens
GB0714530D0 (en) New apparatus and method
HK1148228A1 (en) Method for preparing optionally substituted p-hydroxymandelic compounds and derivatives thereof
TWI370107B (en) Novel methods for making and using halosilylgermanes
EP2233512A4 (en) POLYTHIOETHERIMIDES AND PROCESS FOR PRODUCING THE SAME
EP2305649A4 (en) PROCESS FOR PREPARING A 6-ARYLOXYCHINOLINE DERIVATIVE AND INTERMEDIATE PRODUCT THEREOF
AP2009005063A0 (en) Modified wood and method for producing modified wood
PL2265404T3 (pl) Sposób i aparat do cięcia

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210524